BloombergPortada
Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO
Kailera Therapeutics Inc. shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized US initial public offering.
AP
Avalon Pernell
Redação · Hace 5 h
Kailera Therapeutics Inc. shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized US initial public offering.